Showing results (131-140 of 460) with videos related to

Sort By:
Pageof 46
Rare Tumors|December 9, 2010
Angiomatoid fibrous histiocytoma in a 25-year-old maleAaron Mansfield, Brenda Larson, Scott L Stafford, et al.
Hematology Reports|November 25, 2024
Real-World Study of US Adults with Paroxysmal Nocturnal Hemoglobinuria Treated with PegcetacoplanBrian Mulherin, Apeksha Shenoy, Lily Arnett, et al.
Biochemical and Biophysical Research Communications|November 4, 2004
Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporterDavid Dingli, Elizabeth R Bergert, Zeljko Bajzer, et al.
Cancer|March 29, 2006
Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosisDavid Dingli, Susan M Schwager, Ruben A Mesa, et al.
Blood|March 22, 2003
Genetically targeted radiotherapy for multiple myelomaDavid Dingli, Rosa Maria Diaz, Elizabeth R Bergert, et al.
Molecular Imaging and Biology|December 6, 2005
Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumorDavid Dingli, Brad J Kemp, Michael K O'Connor, et al.
Mayo Clinic Proceedings|August 11, 2018
A Patient With Hereditary ATTR and a Novel AGel p.Ala578Pro AmyloidosisMeera Sridharan, W Edward Highsmith, Paul J Kurtin, et al.
Blood Cancer Journal|March 14, 2018
Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignanciesPraful Ravi, Shaji K Kumar, James R Cerhan, et al.
Annals of Hematology|January 1, 2022
The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient surveyDavid Dingli, Joana E Matos, Kerri Lehrhaupt, et al.
Plos Computational Biology|November 14, 2007
Genetic progression and the waiting time to cancerNiko Beerenwinkel, Tibor Antal, David Dingli, et al.
Pageof 46